Westminster, CO - April 2, 2025 - Asclepius Medical Holdings International, a leader in advanced medical technologies, has announced its acquisition of Shockwave PRO USA, a pioneering company specializing in focused shockwave therapy devices. This move marks a strategic expansion into the rapidly evolving field of non-invasive therapeutic solutions, reinforcing Asclepius Medical Holdings’ commitment to innovation in patient care.
The acquisition follows Asclepius Medical’s 2024 purchase of Abacus Medical, the parent company of Neuropathy Specialists, the largest provider of neuropathy treatment devices in the United States, and Premier Laser Fat Loss Centers USA, the nation’s largest laser fat loss franchise. With this latest acquisition, the company is broadening its footprint in emerging medical device technologies, particularly in focused shockwave therapy—a non-invasive treatment method gaining traction in orthopedics, sports medicine, and rehabilitation.
“Shockwave PRO USA’s dedication to cutting-edge technology and patient-centric innovation aligns seamlessly with our mission,” said Dr. Stephen Falken, CEO of Asclepius Medical Holdings International. “This acquisition is an important step in advancing non-invasive therapeutic solutions and expanding our portfolio of next-generation medical devices.”
Focused Shockwave Therapy: A Growing Medical Trend
Focused shockwave therapy is an emerging treatment modality that uses precisely controlled acoustic waves to stimulate tissue repair, reduce pain, and restore mobility. The technology has demonstrated promising potential in pain management, musculoskeletal rehabilitation, and post-surgical recovery, making it a valuable tool for medical professionals seeking effective alternatives to invasive procedures.
Shockwave PRO USA has built a strong reputation for its state-of-the-art devices, which combine precision engineering with user-friendly design. By integrating Shockwave PRO USA’s technology into its existing medical device portfolio, Asclepius Medical Holdings aims to accelerate the adoption and accessibility of focused shockwave therapy worldwide.
A Strategic Expansion in Medical Innovation
Asclepius Medical Holdings International has historically focused on acquiring large-scale manufacturers but is now strategically investing in disruptive, high-growth companies with breakthrough medical technologies. The acquisition of Shockwave PRO USA underscores the company’s commitment to expanding its presence in the non-invasive treatment sector.
While financial details of the transaction remain undisclosed, the deal reflects Asclepius Medical Holdings’ long-term vision of driving innovation in healthcare through strategic acquisitions and technological advancements.
About Asclepius Medical Holdings International
Asclepius Medical Holdings International is a global leader in the development, manufacturing, and distribution of advanced medical technologies. The company specializes in cutting-edge therapeutic solutions designed to improve patient outcomes across various medical disciplines. With a track record of strategic acquisitions, Asclepius Medical Holdings is committed to advancing non-invasive treatment options that enhance healthcare accessibility and efficiency.
For more information, visit https://pulse-wave.us.
Media Contact
Company Name: Asclepius Medical Holdings International
Contact Person: Dr. Cameron Hall
Email: Send Email
Phone: 720-518-8005
Country: United States
Website: https://pulse-wave.us/